Navigation Links
Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
Date:9/2/2012

VIENNA, Sept. 3, 2012 /PRNewswire/ -- Elevation Pharmaceuticals, Inc. today presented positive efficacy and safety results from the GOLDEN-1 study – a Phase 2b study evaluating EP-101 in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) – at the annual meeting of the European Respiratory Society in Vienna, Austria.  As previously announced, EP-101 demonstrated a rapid onset, dose-related, statistically significant improvement in lung function compared to placebo.  EP-101 is a proprietary inhalation solution formulation of glycopyrrolate, a long-acting muscarinic antagonist (LAMA), delivered by an investigational eFlow® nebulizer (PARI Pharma GmbH). 

The GOLDEN-1 study (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer), was a Phase 2b, randomized, placebo-controlled, double-blind, seven-arm, four-period cross-over, incomplete block design, dose-ranging study with seven days of once-daily dosing to assess the pharmacokinetics, safety and efficacy of EP-101 in 140 patients with moderate-to-severe COPD.  All four doses (25mcg, 50 mcg, 100 mcg and 200 mcg) of EP-101 administered as once daily for seven days using the investigational eFlow provided a rapid onset of action (five minutes), short treatment time (two minutes), and a robust magnitude of bronchodilation compared to placebo.  The bronchodilatory improvements on day seven as assessed by 24-hour forced expiratory volume in one second (FEV1)  and the FEV1 AUC (0-12 hours and 12-24 hours) were dose-dependent, statistically significant (p<0.001) at all doses compared to placebo, and clinically meaningful at several doses compared to placebo.  In addition, the improvements in lung function with EP-101 doses were comparable to those of once-daily tiotropium dry powder inhaler and three- times daily nebulized ipratropium administered via jet nebulizer.
'/>"/>

SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
2. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
3. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
4. Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway
5. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
6. Global RFID in Healthcare and Pharmaceuticals Industry
7. Isis Pharmaceuticals to Present at the 2012 Stifel Nicolaus Healthcare Conference
8. MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares of Common Stock
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. Isis Pharmaceuticals to receive $1.4 million from Alnylam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  In today,s marketplace, launching multiple products for ... as is managing a portfolio of products in the ... - or even preferable - to pool resources to ... combine resources and activities, and what marketing and sales ... just a few of the dilemmas facing pharmaceutical sales, ...
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... and INGELHEIM, Germany, July 6, 2011 As part ... the most promising solutions to challenging health problems around ... the launch of the Making More Health: Achieving ... This worldwide competition invites the most ...
... Inc. (NYSE: RMD and ASX: ... medical equipment for treating, diagnosing and managing sleep-disordered ... it has acquired BiancaMed Ltd., a leading Irish ... outstanding shares with cash.   (Logo: ...
Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3ResMed Announces Acquisition of BiancaMed 2ResMed Announces Acquisition of BiancaMed 3
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... policy that bans blood donations from gay and bisexual men, according ... in the Journal of the American Medical Association . ... cannot donate blood in the United States -- a lifetime ban ... and Drug Administration adopted this policy at the dawn of the ...
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... "We experienced difficulty filling our pill ... two inventors from Jamestown, Calif. "We came up with ... we could pour medications in more easily." , They ... keep the lids open as the pill box is ... compartments have been filled. This eliminates hassles and frustrations, ...
(Date:7/28/2014)... 28, 2014 Scientists in Japan have ... improved blood test for the asbestos cancer mesothelioma. Surviving ... research. Click here to read it now. ... Tokyo’s Juntendo University Graduate School of Medicine say a ... a step above the old test. , “Particularly ...
(Date:7/28/2014)... Hill, South Carolina (PRWEB) July 28, 2014 ... people enjoy their first bite of food best, with ... before. Over-indulging, the researchers found, can actually serve to ... to overindulge in foods they enjoy, not realizing the ... statement. "This is the argument for moderation, if we ...
Breaking Medicine News(10 mins):Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 3Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3
... MIAMI, Oct. 8 Infants and toddlers cannot ... on over-the-counter children,s,medicines, parents need a safe alternative ... been the bulb aspirator. However, these can,irritate a ... In-the-know parents have discovered the safe, effective alternative,that,s ...
... treatment for breast cancer differs between African-American women and ... insurance type. The study appears in the November 15, ... American Cancer Society. , Dr. Mousumi Banerjee of ... from Wayne State University and Dr. William Hryniuk from ...
... progression of age-related macular degeneration (AMD), according to a ... Human Nutrition Research Center on Aging at Tufts University. ... in 7 to 15% of the elderly, according to ... be the most practical and cost-effective prevention method to ...
... BEND, Ind., Oct. 7 OCS, Inc. and,Press ... into a,partnership, whereby the companies have combined their ... of products for the home,health care industry. The ... analysis of interrelated performance metrics integrating,patient satisfaction, patient ...
... The following is a,transcript of a radio address by ... morning., One important commitment of the Federal government ... care. Most of these children are,covered by Medicaid, which ... fiscal year. For children who do not qualify for ...
... Studies link this common problem with vascular disease , , ... realize it, but if they,re having problems achieving or ... Erectile dysfunction, or impotence, affects more than 18 million ... at the Johns Hopkins Bloomberg School of Public Health. ...
Cached Medicine News:Health News:As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines 2Health News:Differences observed between black and white women in use of breast cancer therapy 2Health News:Limiting refined carbohydrates may stall AMD progression 2Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Radio Address by President Bush to the Nation 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3
The Achieva CV brings the power of CMR into routine clinical practice, so you can do more in Cardiovascular MR....
The Clearblue Easy Digital Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the...
These products are primarily for use with paediatric patients and for patients with difficult veins....
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: